Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of Pharmaceutical Sciences
|
June 14, 2020
Deamidation in Moxetumomab Pasudotox Leading to Conformational Change and Immunotoxin Activity Loss
Xiaojun Lu, Shihua Lin, Niluka De Mel, et al.
Journal of Virological Methods
|
June 12, 2017
Biophysical characterization of influenza A virions
Arun Parupudi, Flaviu Gruia, Samuel A Korman, et al.
Journal of Pharmaceutical Sciences
|
June 25, 2013
A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies
Reza Esfandiary, David B Hayes, Arun Parupudi, et al.
Journal of Pharmaceutical Sciences
|
November 15, 2012
A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies
Reza Esfandiary, David B Hayes, Arun Parupudi, et al.
Scientific Reports
|
March 12, 2021
Global multi-method analysis of interaction parameters for reversibly self-associating macromolecules at high concentrations
Arun Parupudi, Sumit K Chaturvedi, Regina Adão, et al.
Mabs
|
September 5, 2020
Measuring aggregates, self-association, and weak interactions in concentrated therapeutic antibody solutions
Sumit K Chaturvedi, Arun Parupudi, Kristian Juul-Madsen, et al.
Molecular Therapy. Methods & Clinical Development
|
December 17, 2024
Size-exclusion chromatography as a multi-attribute method for process and product characterization of adeno-associated virus
Sri Hari Raju Mulagapati, Arun Parupudi, Tomasz Witkos, et al.
Journal of Pharmaceutical Sciences
|
October 30, 2016
Both Reversible Self-Association and Structural Changes Underpin Molecular Viscoelasticity of mAb Solutions
Prasad S Sarangapani, Justin Weaver, Arun Parupudi, et al.
Mabs
|
December 8, 2022
Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies
Andrew Dippel, Austin Gallegos, Vineela Aleti, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of Pharmaceutical Sciences
|
June 14, 2020
Deamidation in Moxetumomab Pasudotox Leading to Conformational Change and Immunotoxin Activity Loss
Xiaojun Lu, Shihua Lin, Niluka De Mel, et al.
Journal of Virological Methods
|
June 12, 2017
Biophysical characterization of influenza A virions
Arun Parupudi, Flaviu Gruia, Samuel A Korman, et al.
Journal of Pharmaceutical Sciences
|
June 25, 2013
A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies
Reza Esfandiary, David B Hayes, Arun Parupudi, et al.
Journal of Pharmaceutical Sciences
|
November 15, 2012
A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies
Reza Esfandiary, David B Hayes, Arun Parupudi, et al.
Scientific Reports
|
March 12, 2021
Global multi-method analysis of interaction parameters for reversibly self-associating macromolecules at high concentrations
Arun Parupudi, Sumit K Chaturvedi, Regina Adão, et al.
Mabs
|
September 5, 2020
Measuring aggregates, self-association, and weak interactions in concentrated therapeutic antibody solutions
Sumit K Chaturvedi, Arun Parupudi, Kristian Juul-Madsen, et al.
Molecular Therapy. Methods & Clinical Development
|
December 17, 2024
Size-exclusion chromatography as a multi-attribute method for process and product characterization of adeno-associated virus
Sri Hari Raju Mulagapati, Arun Parupudi, Tomasz Witkos, et al.
Journal of Pharmaceutical Sciences
|
October 30, 2016
Both Reversible Self-Association and Structural Changes Underpin Molecular Viscoelasticity of mAb Solutions
Prasad S Sarangapani, Justin Weaver, Arun Parupudi, et al.
Mabs
|
December 8, 2022
Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies
Andrew Dippel, Austin Gallegos, Vineela Aleti, et al.
Page
of 2